London, England, United Kingdom In 2005 was created London Technology Fund, which is appeared as VC. The main office of represented VC is situated in the London. The venture was found in Europe in United Kingdom.
Besides, a startup needs to be aged 4-5 years to get the investment from the fund. We can highlight the next thriving fund investment areas, such as Biotechnology, Product Design. Among the most popular portfolio startups of the fund, we may highlight Immune Targeting Systems, deltaDOT. For fund there is a match between the location of its establishment and the land of its numerous investments - United Kingdom.
The usual cause for the fund is to invest in rounds with 2-3 partakers. Despite the London Technology Fund, startups are often financed by Truffle Capital, Novartis Venture Fund, Nikko Principal Investments. The meaningful sponsors for the fund in investment in the same round are Truffle Capital, Novartis Venture Fund, Imperial Innovations. In the next rounds fund is usually obtained by Truffle Capital, Royal Society Enterprise Fund, Novartis Venture Fund.
Opposing the other organizations, this London Technology Fund works on 12 percentage points less the average amount of lead investments. The fund is generally included in less than 2 deals every year. Considering the real fund results, this VC is 13 percentage points more often commits exit comparing to other organizations. The common things for fund are deals in the range of 1 - 5 millions dollars. The top activity for fund was in 2007. The top amount of exits for fund were in 2015.
Related Funds
Funds with similar focus
| Fund Name | Location |
| Anania & Associates Investment Company | - |
| Fisher Brothers | New York, New York, United States |
| Harmony Investments | United States, Virginia, Virginia Beach |
| HPC Capital | France, Languedoc-Roussillon, Montpellier |
| Huimei Touzi | China, Hangzhou, Zhejiang |
| J.Gold Stone Capital (HK) | China, Hong Kong, Hong Kong Island |
| NUS Enterprise | Central, Central Region, Singapore |
| Youyi Gao Zichan | China, Guangdong Province, Longgang District |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Immune Targeting Systems | $13M | 17 Mar 2010 | England | ||
| $4M | 16 Jul 2007 | England |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Immune Targeting Systems | $13M | 17 Mar 2010 | England | ||
| $4M | 16 Jul 2007 | England |
